Viri Sode

Product NDC

83027-0150

11-digit product format

830270150

Labeler code

83027

Product ID

83027-0150_aa330e58-bbfc-474e-8d9e-31d649bfe238

Type

HUMAN OTC DRUG

Nonproprietary name

Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode

Dosage form

SPRAY

Route

ORAL

Labeler

Nutritional Specialties, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2025-06-03

Marketing end

2030-05-07

Substance

HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; RUBELLA VIRUS

Active strength

30; 30; 30; 16; 16; 15; 15; 16; 15; 15; 15; 15; 16 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL

NDC exclude flag

No

Current FDA listing

Yes